Management of hepatitis C virus infection in HIV/HCV co-infected patients: Clinical review

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 30

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. Aug 14, 2009; 15(30): 3713-3724
Published online Aug 14, 2009. doi: 10.3748/wjg.15.3713

Table 3 Barriers against anti-HCV therapy in co-infected patients

Patient-related factors

Active substance abuse

Concern regarding adverse effects

Cost of treatment

Lack of social support

Lack of transport

Number of pills and dosing frequency (including HAART)

Physician-related factors

Lack of experience

Lack of awareness

Lack of motivation for referral

Fear of adverse effects

HAART: Highly active anti-retroviral therapy.

Citation: Singal AK, Anand BS. Management of hepatitis C virus infection in HIV/HCV co-infected patients: Clinical review. World J Gastroenterol 2009; 15(30): 3713-3724
URL: https://www.wjgnet.com/1007-9327/full/v15/i30/3713.htm
DOI: https://dx.doi.org/10.3748/wjg.15.3713

Singal AK, Anand BS. Management of hepatitis C virus infection in HIV/HCV co-infected patients: Clinical review. World J Gastroenterol 2009; 15(30): 3713-3724 [PMID: 19673011 DOI: 10.3748/wjg.15.3713]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.